NASDAQ:CRVS   Corvus Pharmaceuticals, Inc
Multiple insider buying, huge institutional purchase at $3.50, and clear stop-loss below it. Low risk high reward play. First target is $5.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.